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Background
Chronic spontaneous urticaria (CSU) is defined as urti-
caria persisting for more than 6 weeks. An autoimmune
basis is held responsible for more than half the cases. In
this questionnaire study, we examined responses to
treatment, current urticarial activity, effect on lifestyle,
frequency of hospital visits, beliefs of causation, and
satisfaction with treatment method.
Methods
The patients were ascertained from the patients seen in
the Division of Dermatology at the University of
Saskatchewan. 173 patients with CSU had been seen
between 2003 and 2013 and an autologous serum skin
test (ASST) had been performed on 138 patients.
101 participants responded.
Results
In the original cohort there were significantly more
females than males (130:43). The ASST was positive in
58 patients (42.02%), and only a quarter of these were
men (M: F; 12:46).
Of the respondents, 80 were women and 21 men. The
age range was 1 year to 81. The mean age was 36 years.
The average duration of symptoms was 9.3 years. They
included 40 patients who were ASST positive (M: F; 8:32)
and 49 negative M:F; 12:37 ). 50 participants no longer
had hives. Patients reported being most bothered by
pruritus, disturbed sleep, anxiety and their physical
appearance including facial swelling. Many (71.2%) had
missed work or school because of the urticaria. Almost
22% of participants attributed stress to be a major cause
of their CSU.
Twenty-nine patients found antihistamines alone gave
adequate relief of urticaria. Prednisone, as prescribed by
emergency room physicians and family practitioners,
was added as treatment in about a fifth of all the
participants.
Twenty ASST positive patients with severe uncontrolla-
ble hives were treated with intravenous immunoglobulin
(IVIG) available to the patients at no cost through
Canadian Blood Transfusion Services. 85.0% of these
patients had improved quality of life, with 13 of these
patients were now free of urticaria and no longer receiv-
ing IVIG. Three patients who did not benefit from IVIG
did respond to methotrexate. None of the ASST negative
patients received IVIG.
Conclusion
In this follow-up questionnaire study, about 30% of
patients found antihistamines gave effective control.
Half the patients had been free of urticaria for at least
3 months. About 40% of patients with CSU had an
autoimmune basis as assessed by the ASST and IVIG
was a highly effective treatment for this group.
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